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Recent evidence suggests that the pleiotropic effects of interferon are triggered  by 
the  rapid  binding  of interferon  to  cells,  probably  to  a  membrane  receptor  that 
contains, in part, ganglioside (1-5). A  brief lag period has been observed between the 
initial binding of interferon to cells and the subsequent establishment of the anti-viral 
state. This lag probably corresponds to a series of cellular events initiated by interferon 
binding (6). 
Interferon  treatment  of cells  also  results  in  modifications  in  the  structure  and 
function  of  cells  (7).  We  have  recently  characterized  the  main  features  of  the 
phenotype of interferon-treated human fibroblasts (8, 9)) The phenotypic alterations 
include decreased rates of cell proliferation and cell movement; increased cell surface 
area, volume, and mass; altered organization and size of actin-containing cytoplasmic 
fibers; increased organization of cell surface fibronectin; and increased rigidity of the 
plasma membrane. 
In this report, we examine the effects of interferon treatment on the lateral mobility 
of the  cell  surface  receptors  for  the  lectin  concanavalin  A  (Con  A).  Study  of the 
interaction  of interferon  with  the  cell  surface  may clarify the  mechanism  whereby 
interferon initiates  a complex series of changes in cell structure and function. 
Materials  and Methods 
Cells.  HeLa-S3  cells  were  grown  in  suspension  in  the  spinner  modification  of Eagle's 
minimum essential  medium  (spinner medium)  supplemented  with 4%  fetal calf serum. The 
initial  cell  concentration was 2 ×  104 cells/ml.  At  1 d  after subcuhuring, human fibroblast 
interferon was added at concentranons varying from 10 to 640 U/ml; control cultures received 
no interferon. 
Interferon  Two interferon preparations,  produced in human fibroblasts that were induced 
with polymosinic, polycytidylic acid, were used. A partially purified preparation, provided by 
Dr. W. Carter and Dr. J. Horoszewicz of Roswell Park Memorial Institute, Buffalo, N. Y., had 
a 2 ×  107 U/rag of protein sp act. It was purified by chromatography on Con A-agarose and 
phenyl-Sepharose  (Pharmacia  Fine  Chemicals,  Div  of Pharmacia,  Inc.,  Piseataway$  N. J.) 
columns in tandem.  A  preparation  of interferon purified  to homogeneity (>2  ×  10  U/rag 
protein sp act) was provided by Dr. E. Knight, Jr. of E. I. Du Pont de Nemours & Co., Inc., 
Wilmington, Del. Interferon activity was assayed by a microtitration procedure with vesicular 
stomatitis virus as previously described (10), using the World Health Organization international 
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human fibroblast reference standard (Nauonal Institutes of Health catalog number G-023-902- 
527)  for comparison 
Results and Discussion 
As is shown in Fig.  1 A and B, when either control or interferon-treated HeLa-S3 
cells are incubated at 4°C with fluorescein-conjugated Con A (fl-Con A) (Calbiochem- 
FIG  [.  Effect  of interferon treatment on the redistribution of Con A receptors  At  72 h  after the 
beginning of treatment, aliquots of ~2 ×  105 cells were removed from control and interferon-treated 
(640 U/ml) cultures, pelleted, resuspended m  I ml of spinner medium that contained 2 `ag/ml of fl- 
Con A, and the cells maintained at 4°C for 4.5 ram. The cells were pelleted and resuspended m 3 7qr 
formaldehyde m  phosphate-buffered saline (PBS)  (A and B), or m spinner medium in which the? 
were incubated at 37°C for 60-90 mm before fixation m formaldehyde at room temperature for 10- 
20 mm (C and D)  The cells were then resuspended m 50 `al PBS and 50 .ILl twice-buffered glycerol- 
PBS (l  1 vol/vol) and examined m a Zelss III RS photomlcroscope eqwpped with eplfluorescence 
and phase-contrast optics (Carl Zelss, Inc, New York)  (A) Control cells and (B) lnterferon-IPreated 
cells maintained at 40C with fl-Con A, (C) Control cells and (D) interferon-treated cells warmed to 
37°C  Fluorescence staining is shown at left,  phase contrast is shown at right  Note that m control 
cells  (C) the cap is in an extended portion of the cell  In interferon-treated cells,  patched areas of 
fluorescence (arrows) are found m cells  that remain essentmlly round  White hne m A-C is  l ,am+ 
white hne in D is 1 ktm PFEFFER  ET  AL  BRIEF  DEFINITIVE REPORT  471 
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FIG  2  Effect of interferon concentration on the redistribution of Con A receptors  HeLa-S3 cells 
were grown and treated with human fibroblast  interferon at concentrations varfing from  l0 to 640 
Lo  5  U/ml. At 48 h after the beginning of interferon treatment, ahquots of 2 ×  l0 -5 ×  10  cells were 
removed from control and interferon-treated cultures and the cells were processed for an examination 
of Con A-receptor distribution as described  in the legend to Fig  I. Cells were examined for the 
fluorescence pattern of fl-Con A and scored  for the presence  of intense fluorescence  at one pole of 
the cell (cap formation)  At least 500 cells were scored  for each point. At 72 h from the beginning 
of interferon  treatment,  a  slmdar  dose-response  curve  was  obtained.  Under  the  experimental 
conditions used,  -95%  of the control  HeLa-S3 cells  showed  capping of fl-Con A. The optimal 
concentration of fl-Con A is markedly dependent on the type of cell studied  The redistnbutmn of 
Con A receptors  is inhibited at high concentrations of fl-Con A  When control HeLa-S3 cells were 
incubated with fl-Con A at 50 ~g/ml at 4°C, and then warmed to 37°C, <45% of the cells showed 
capping of fl-Con A  Data are expressed as follows 
percent of interferon-treated cells capped x  100 
percent of control cells capped 
Behring  Corp.,  American  Hoechst  Corp.,  San  Diego,  Calif.)  before  fixation  with 
formalin, a  diffuse pattern  of fluorescence is observed over the entire cell surface. 
If control cells are incubated with fl-Con A  at 4°C, washed with fresh medium,  and 
then  incubated  at  37°C  for 60-90  min,  the diffuse surface  fluorescence redistributes 
and  becomes concentrated  at one pole of the cell forming a  cap, as illustrated  in Fig. 
1 C  Electron microscopic observation of cells incubated with ferritin-conjugated Con 
A  has indicated that most of the Con A  is bound  to the surface and little is internalized 
after 60-90  min at  37°C. 
In  contrast  to  the  findings  obtained  with  control  cells,  incubation  of interferon- 
treated  HeLa-S3  cells  at  37°C  after  fl-Con  A  pretreatment  at  4°C  results  in  a 
redistribution  of  Con  A  receptors  into  a  pattern  of  patched  regions  of  surface 
fluorescence  (Fig.  1 D). At an interferon concentration  of 640 U/ml,  cap formation  is 
largely  inhibited  even  when  incubation  at  37°C  after  fl-Con  A  pretreatment  is 
extended to  180 min. The extent of inhibition of cap formation is dependent  upon the 
interferon dose used  (Fig. 2).2 The approximately  exponential  dose-response  relation- 
ship  for  inhibition  of capping  is  similar  to  that  obtained  for  the  inhibition  of cell 
proliferation and  of virus multiplication  by interferon. 
Mouse and  chick interferons  were not effective in  the inhibition  of cap  formation, 
suggesting  that  interferon  itself  was  the  species-specific  agent  responsible  for  the 
observed effect. 
2 Recently,  Matsuyama  (Matsuyama,  M.  1979 Action  of interferon  on  cell  membrane  of mouse 
lymphocytes.  Exp  Cell Res  124:253.) has  reported  that  mouse  interferon  inhibited  capping of certain 
surface components on mouse lymphocytes, which react with anti-lymphocyte serum or lectlns Only those 
surface  receptors  whose  capping was  enhanced  by  pretreatment  of lymphocytes with colchlcme were 
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F~e  3  Time-course of interferon-reduced mhlbmon of capping of Con A receptors  HeLa-S3 cells 
were grown and treated with human fibroblast interferon as described m legend for Fig  1 At 1, 3, 
6,  12, 24, 36, 48, and 72 h after the beginmng  of treatment, cell aliquots  were processed for a 
determmation  of ablhty to redistribute  fl-Con A into caps  At least 500 cells were scored for each 
point The control values for capping of fl-Con A were 96, 96, 97, 97, 96, 96, 97, and 96% of the cell 
population at 1, 3, 6, 12, 24, 36, 48, and 72 h, respecttvely 
Fig. 3  shows  the time-course of development of inhibition of lateral movement  of 
Con A  receptors in interferon-treated (640 U/ml) cells. Interferon treatment  for only 
3 h  is sufficient to cause a  15% reduction in capping. A  maximal inhibition of ~85% 
is reached within 36 h from the beginning of treatment. Two preparations of fibroblast 
interferon with different specific activities, one of which was purified to homogeneity, 
gave closely similar results. We have shown  previously that  human  fibroblast inter- 
feron (640 U/ml) causes a 60% reduction in the rate of proliferation of HeLa-S3 cells, 
and that this effect is manifest within 24 h  from the beginning of treatment  (8). 
It  has  been  demonstrated  in  several cell culture  systems that  (Ion  A  binding  to 
membrane  receptors occurs rapidly at 4°(2  (11-13).  When cells are then  warmed  to 
37°C, the receptors, which are cross-linked by Con A, are rapidly redistributed within 
the plane of the membrane to form: first, patchy regions containing multiple receptor- 
Con A complexes, and ultimately, large aggregates in the form of a cap at one pole of 
the cell (13,  14). The redistribution of the cross-linked Con A  receptors is sensitive to 
cytochalasin B (11, 15), which impairs the function of submembranous m icrofilaments 
(16,  17). 
In previous studies  (9)  we  have  reported  that  treatment  of human  fibroblasts in 
culture  with  human  fibroblast  interferon  (640  U/ml)  causes  not  only  a  55-60% 
reduction in the rate of cell proliferation, but  also causes a  70%  decrease in  the rate 
of cell movement  in 48  h.  In other laboratories (16,  18-22),  a  close relationship has 
been  established between  the organization of submembranous  actin-containing ml- 
crofilaments and several aspects of cell locomotion in fibroblasts. The kinetics of the 
interferon-induced inhibition of lateral mobility of cell surface receptors  (cf.  Fig. 3) 
and  of cell  movement  (9)  are strikingly similar.  Because  these  motile activities are 
intimately associated with the cellular contractile machinery, an attractive hypothesis PFEFFER ET AL  BRIEF  DEFINITIVE REPORT  473 
to explain the interferon-induced inhibition of lateral mobility of  cell surface receptors 
and of cell movement is that such inhibition results from an alteration in the state of 
microfilaments, We have demonstrated that interferon treatment of  human fibroblasts 
markedly alters the organization of cytoplasmic microfilaments (9). 1 Very large and 
numerous microfilament  bundles  are  formed spanning the  length  of enlarged  cells 
(9). 1 Experiments are in progress to determine whether interferon treatment alters the 
organization of microfilaments in HeLa-S3 cells,  and if so, how the alterations may 
be  related  to  the  inhibition  of cell  proliferation  and  of the  lateral  mobility of cell 
surface receptors. 
There  is  also  evidence  that  interferon  treatment  of HeLa-S3  cells  and  human 
fibroblasts increases the rigidity of the plasma membrane lipid bilayer, t This could be 
a  contributing factor in  the  inhibition  of the  lateral  mobility of lectin  receptors as 
well as of cell movement in interferon-treated cells. 
Interferon treatment  of cells  elicits  a  coordinated response that  involves the cell 
membrane  with  its  associated  proteins  and  also  the  cytoplasmic  microfilaments. 
Further work is needed to distinguish clearly between the initial effects of interferon 
on  cells  and  those  that  represent  phenotypic  changes  that  are  secondary  to  the 
decreased cycling activity of treated cells. 
Summary 
Interferon treatment impairs the ability of cells to redistribute cell surface receptors 
for concanavalin A  (Con A). The effect of interferon becomes evident within  3-6 h 
and is maximal within 36-48 h. Highly purified human fibroblast interferon  (>2 × 
l0  s  U/mg of protein  sp  act;  concentration:  640 U/ml)  caused  ~85%  inhibition  of 
capping of fluorescein-conjugated Con A  in interferon-sensitive HeLa-S3 cells  at  36 
h from the beginning of treatment. 
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